Skip to main content
PMC home page
Journal of Virology logoLink to Journal of Virology
. 1997 Jun;71(6):4226–4232. doi: 10.1128/jvi.71.6.4226-4232.1997

Activation of endothelial cells via antibody-enhanced dengue virus infection of peripheral blood monocytes.

R Anderson 1, S Wang 1, C Osiowy 1, A C Issekutz 1
PMCID: PMC191637  PMID: 9151809

Abstract

Although endothelial cells have been speculated to be a target in the pathogenesis of dengue hemorrhagic fever (DHF), there has been little evidence linking dengue virus infection to any alteration in endothelial cell function. In this study, we show that human umbilical vein endothelial cells become activated when exposed to culture fluids from dengue virus-infected peripheral blood monocytes. Maximum activation was achieved with culture fluids from monocytes in which virus infection was enhanced by the addition of dengue virus-immune serum, thus correlating with epidemiological evidence that prior immunity to dengue virus is a major risk factor for DHF. Activation was strongest for endothelial cell expression of VCAM-1 and ICAM-1. In contrast, activation of endothelial cell E-selectin expression appeared to be more transient, as indicated by its detection at 3 h, but not at 16 h, of treatment. Treatment of monocyte culture fluids with anti-tumor necrosis factor alpha (TNF-alpha) antibody largely abolished the activation effect (as measured by endothelial cell expression of ICAM-1), whereas treatment with IL-1beta receptor antagonist had a much smaller inhibitory effect on activation. Endothelial cells inoculated directly with dengue virus or with virus-antibody combinations were poorly infectable (compared to Vero cells or peripheral blood monocytes), and virus-inoculated endothelial cells showed no increased expression of VCAM-1, ICAM-1, or E-selectin. Taken together, the results strongly indicate that dengue virus can modulate endothelial cell function by an indirect route, in which a key intermediary is TNF-alpha released from virus-infected monocytes.

Full Text

The Full Text of this article is available as a PDF (629.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aarli A., Matre R., Thunold S. IgG Fc receptors on epithelial cells of distal tubuli and on endothelial cells in human kidney. Int Arch Allergy Appl Immunol. 1991;95(1):64–69. doi: 10.1159/000235456. [DOI] [PubMed] [Google Scholar]
  2. Andrews B. S., Theofilopoulos A. N., Peters C. J., Loskutoff D. J., Brandt W. E., Dixon F. J. Replication of dengue and junin viruses in cultured rabbit and human endothelial cells. Infect Immun. 1978 Jun;20(3):776–781. doi: 10.1128/iai.20.3.776-781.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Antibody-dependent enhancement of HIV infection. Lancet. 1988 Jun 4;1(8597):1285–1286. [PubMed] [Google Scholar]
  4. Antibody-dependent enhancement of HIV infection. Lancet. 1988 Jun 4;1(8597):1285–1286. [PubMed] [Google Scholar]
  5. Beutler B., Grau G. E. Tumor necrosis factor in the pathogenesis of infectious diseases. Crit Care Med. 1993 Oct;21(10 Suppl):S423–S435. [PubMed] [Google Scholar]
  6. Bevilacqua M. P. Endothelial-leukocyte adhesion molecules. Annu Rev Immunol. 1993;11:767–804. doi: 10.1146/annurev.iy.11.040193.004003. [DOI] [PubMed] [Google Scholar]
  7. Brandt W. E., McCown J. M., Gentry M. K., Russell P. K. Infection enhancement of dengue type 2 virus in the U-937 human monocyte cell line by antibodies to flavivirus cross-reactive determinants. Infect Immun. 1982 Jun;36(3):1036–1041. doi: 10.1128/iai.36.3.1036-1041.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Brandt W. E., McCown J. M., Top F. H., Jr, Bancroft W. H., Russell P. K. Effect of passage history on dengue-2 virus replication in subpopulations of human leukocytes. Infect Immun. 1979 Nov;26(2):534–541. doi: 10.1128/iai.26.2.534-541.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Braquet P., Touqui L., Shen T. Y., Vargaftig B. B. Perspectives in platelet-activating factor research. Pharmacol Rev. 1987 Jun;39(2):97–145. [PubMed] [Google Scholar]
  10. Carlos T. M., Harlan J. M. Leukocyte-endothelial adhesion molecules. Blood. 1994 Oct 1;84(7):2068–2101. [PubMed] [Google Scholar]
  11. Cosgriff T. M. Viruses and hemostasis. Rev Infect Dis. 1989 May-Jun;11 (Suppl 4):S672–S688. doi: 10.1093/clinids/11.supplement_4.s672. [DOI] [PubMed] [Google Scholar]
  12. Daughaday C. C., Brandt W. E., McCown J. M., Russell P. K. Evidence for two mechanisms of dengue virus infection of adherent human monocytes: trypsin-sensitive virus receptors and trypsin-resistant immune complex receptors. Infect Immun. 1981 May;32(2):469–473. doi: 10.1128/iai.32.2.469-473.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Dinarello C. A. The proinflammatory cytokines interleukin-1 and tumor necrosis factor and treatment of the septic shock syndrome. J Infect Dis. 1991 Jun;163(6):1177–1184. doi: 10.1093/infdis/163.6.1177. [DOI] [PubMed] [Google Scholar]
  14. Fisher-Hoch S. P., Platt G. S., Neild G. H., Southee T., Baskerville A., Raymond R. T., Lloyd G., Simpson D. I. Pathophysiology of shock and hemorrhage in a fulminating viral infection (Ebola). J Infect Dis. 1985 Nov;152(5):887–894. doi: 10.1093/infdis/152.5.887. [DOI] [PubMed] [Google Scholar]
  15. Gimenez H. B., Keir H. M., Cash P. In vitro enhancement of respiratory syncytial virus infection of U937 cells by human sera. J Gen Virol. 1989 Jan;70(Pt 1):89–96. doi: 10.1099/0022-1317-70-1-89. [DOI] [PubMed] [Google Scholar]
  16. Halstead S. B. Antibody, macrophages, dengue virus infection, shock, and hemorrhage: a pathogenetic cascade. Rev Infect Dis. 1989 May-Jun;11 (Suppl 4):S830–S839. doi: 10.1093/clinids/11.supplement_4.s830. [DOI] [PubMed] [Google Scholar]
  17. Halstead S. B., O'Rourke E. J. Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody. J Exp Med. 1977 Jul 1;146(1):201–217. doi: 10.1084/jem.146.1.201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Halstead S. B. Pathogenesis of dengue: challenges to molecular biology. Science. 1988 Jan 29;239(4839):476–481. doi: 10.1126/science.3277268. [DOI] [PubMed] [Google Scholar]
  19. Halstead S. B., Porterfield J. S., O'Rourke E. J. Enhancement of dengue virus infection in monocytes by flavivirus antisera. Am J Trop Med Hyg. 1980 Jul;29(4):638–642. doi: 10.4269/ajtmh.1980.29.638. [DOI] [PubMed] [Google Scholar]
  20. Halstead S. B., Simasthien P. Observations related to the pathogenesis of dengue hemorrhagic fever. II. Antigenic and biologic properties of dengue viruses and their association with disease response in the host. Yale J Biol Med. 1970 Apr;42(5):276–292. [PMC free article] [PubMed] [Google Scholar]
  21. He R. T., Innis B. L., Nisalak A., Usawattanakul W., Wang S., Kalayanarooj S., Anderson R. Antibodies that block virus attachment to Vero cells are a major component of the human neutralizing antibody response against dengue virus type 2. J Med Virol. 1995 Apr;45(4):451–461. doi: 10.1002/jmv.1890450417. [DOI] [PubMed] [Google Scholar]
  22. Hober D., Poli L., Roblin B., Gestas P., Chungue E., Granic G., Imbert P., Pecarere J. L., Vergez-Pascal R., Wattre P. Serum levels of tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), and interleukin-1 beta (IL-1 beta) in dengue-infected patients. Am J Trop Med Hyg. 1993 Mar;48(3):324–331. doi: 10.4269/ajtmh.1993.48.324. [DOI] [PubMed] [Google Scholar]
  23. Hofman F. M., Wright A. D., Dohadwala M. M., Wong-Staal F., Walker S. M. Exogenous tat protein activates human endothelial cells. Blood. 1993 Nov 1;82(9):2774–2780. [PubMed] [Google Scholar]
  24. Innis B. L., Nisalak A., Nimmannitya S., Kusalerdchariya S., Chongswasdi V., Suntayakorn S., Puttisri P., Hoke C. H. An enzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis co-circulate. Am J Trop Med Hyg. 1989 Apr;40(4):418–427. doi: 10.4269/ajtmh.1989.40.418. [DOI] [PubMed] [Google Scholar]
  25. Issekutz A. C., Lopes N. Endotoxin activation of endothelium for polymorphonuclear leucocyte transendothelial migration and modulation by interferon-gamma. Immunology. 1993 Aug;79(4):600–607. [PMC free article] [PubMed] [Google Scholar]
  26. Jaffe E. A., Nachman R. L., Becker C. G., Minick C. R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest. 1973 Nov;52(11):2745–2756. doi: 10.1172/JCI107470. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Jirik F. R., Podor T. J., Hirano T., Kishimoto T., Loskutoff D. J., Carson D. A., Lotz M. Bacterial lipopolysaccharide and inflammatory mediators augment IL-6 secretion by human endothelial cells. J Immunol. 1989 Jan 1;142(1):144–147. [PubMed] [Google Scholar]
  28. Joubert J. R., King J. B., Rossouw D. J., Cooper R. A nosocomial outbreak of Crimean-Congo haemorrhagic fever at Tygerberg Hospital. Part III. Clinical pathology and pathogenesis. S Afr Med J. 1985 Nov 9;68(10):722–728. [PubMed] [Google Scholar]
  29. Killen H., O'Sullivan M. A. Detection of dengue virus by in situ hybridization. J Virol Methods. 1993 Feb;41(2):135–146. doi: 10.1016/0166-0934(93)90121-7. [DOI] [PubMed] [Google Scholar]
  30. Kliks S. C., Nimmanitya S., Nisalak A., Burke D. S. Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. Am J Trop Med Hyg. 1988 Mar;38(2):411–419. doi: 10.4269/ajtmh.1988.38.411. [DOI] [PubMed] [Google Scholar]
  31. Kliks S. C., Nisalak A., Brandt W. E., Wahl L., Burke D. S. Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. Am J Trop Med Hyg. 1989 Apr;40(4):444–451. doi: 10.4269/ajtmh.1989.40.444. [DOI] [PubMed] [Google Scholar]
  32. Krilov L. R., Anderson L. J., Marcoux L., Bonagura V. R., Wedgwood J. F. Antibody-mediated enhancement of respiratory syncytial virus infection in two monocyte/macrophage cell lines. J Infect Dis. 1989 Nov;160(5):777–782. doi: 10.1093/infdis/160.5.777. [DOI] [PubMed] [Google Scholar]
  33. Kurane I., Rothman A. L., Livingston P. G., Green S., Gagnon S. J., Janus J., Innis B. L., Nimmannitya S., Nisalak A., Ennis F. A. Immunopathologic mechanisms of dengue hemorrhagic fever and dengue shock syndrome. Arch Virol Suppl. 1994;9:59–64. doi: 10.1007/978-3-7091-9326-6_7. [DOI] [PubMed] [Google Scholar]
  34. Lefer A. M. Significance of lipid mediators in shock states. Circ Shock. 1989 Jan;27(1):3–12. [PubMed] [Google Scholar]
  35. Maruo N., Morita I., Shirao M., Murota S. IL-6 increases endothelial permeability in vitro. Endocrinology. 1992 Aug;131(2):710–714. doi: 10.1210/endo.131.2.1639018. [DOI] [PubMed] [Google Scholar]
  36. Meltzer M. S., Skillman D. R., Hoover D. L., Hanson B. D., Turpin J. A., Kalter D. C., Gendelman H. E. Macrophages and the human immunodeficiency virus. Immunol Today. 1990 Jun;11(6):217–223. doi: 10.1016/0167-5699(90)90086-o. [DOI] [PubMed] [Google Scholar]
  37. Morens D. M., Halstead S. B. Measurement of antibody-dependent infection enhancement of four dengue virus serotypes by monoclonal and polyclonal antibodies. J Gen Virol. 1990 Dec;71(Pt 12):2909–2914. doi: 10.1099/0022-1317-71-12-2909. [DOI] [PubMed] [Google Scholar]
  38. Nottet H. S., Gendelman H. E. Unraveling the neuroimmune mechanisms for the HIV-1-associated cognitive/motor complex. Immunol Today. 1995 Sep;16(9):441–448. doi: 10.1016/0167-5699(95)80022-0. [DOI] [PubMed] [Google Scholar]
  39. Ochiai H., Kurokawa M., Hayashi K., Niwayama S. Antibody-mediated growth of influenza A NWS virus in macrophagelike cell line P388D1. J Virol. 1988 Jan;62(1):20–26. doi: 10.1128/jvi.62.1.20-26.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Osiowy C., Horne D., Anderson R. Antibody-dependent enhancement of respiratory syncytial virus infection by sera from young infants. Clin Diagn Lab Immunol. 1994 Nov;1(6):670–677. doi: 10.1128/cdli.1.6.670-677.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Peiris J. S., Gordon S., Unkeless J. C., Porterfield J. S. Monoclonal anti-Fc receptor IgG blocks antibody enhancement of viral replication in macrophages. Nature. 1981 Jan 15;289(5794):189–191. doi: 10.1038/289189a0. [DOI] [PubMed] [Google Scholar]
  42. Robinson W. E., Jr, Montefiori D. C., Mitchell W. M. Antibody-dependent enhancement of human immunodeficiency virus type 1 infection. Lancet. 1988 Apr 9;1(8589):790–794. doi: 10.1016/s0140-6736(88)91657-1. [DOI] [PubMed] [Google Scholar]
  43. Rosenberg Z. F., Fauci A. S. Immunopathogenic mechanisms of HIV infection: cytokine induction of HIV expression. Immunol Today. 1990 May;11(5):176–180. doi: 10.1016/0167-5699(90)90070-p. [DOI] [PubMed] [Google Scholar]
  44. Schnittler H. J., Mahner F., Drenckhahn D., Klenk H. D., Feldmann H. Replication of Marburg virus in human endothelial cells. A possible mechanism for the development of viral hemorrhagic disease. J Clin Invest. 1993 Apr;91(4):1301–1309. doi: 10.1172/JCI116329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Sedmak D. D., Davis D. H., Singh U., van de Winkel J. G., Anderson C. L. Expression of IgG Fc receptor antigens in placenta and on endothelial cells in humans. An immunohistochemical study. Am J Pathol. 1991 Jan;138(1):175–181. [PMC free article] [PubMed] [Google Scholar]
  46. Takeda A., Tuazon C. U., Ennis F. A. Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry. Science. 1988 Oct 28;242(4878):580–583. doi: 10.1126/science.2972065. [DOI] [PubMed] [Google Scholar]
  47. Tamura M., Webster R. G., Ennis F. A. Subtype cross-reactive, infection-enhancing antibody responses to influenza A viruses. J Virol. 1994 Jun;68(6):3499–3504. doi: 10.1128/jvi.68.6.3499-3504.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Vitarana T., de Silva H., Withana N., Gunasekera C. Elevated tumour necrosis factor in dengue fever and dengue haemorrhagic fever. Ceylon Med J. 1991 Jun;36(2):63–65. [PubMed] [Google Scholar]
  49. Whelan J. Selectin synthesis and inflammation. Trends Biochem Sci. 1996 Feb;21(2):65–69. [PubMed] [Google Scholar]
  50. Yadav M., Kamath K. R., Iyngkaran N., Sinniah M. Dengue haemorrhagic fever and dengue shock syndrome: are they tumour necrosis factor-mediated disorders? FEMS Microbiol Immunol. 1991 Dec;4(1):45–49. doi: 10.1111/j.1574-6968.1991.tb04969.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES